NASDAQ:ASBP | Profit Breakdown | Aspire Biopharma Holdings, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$63,104.00-$30,086.00-$2.68M-$1.27M-$1.27M
2026-03-31$28,353.00$5,750.00-$1.65M-$3.22M-$3.22M
2025-12-31$4,261.00-$1,000.00-$1.85M-$4.71M
2025-09-30$1,941.00$884.00-$1.15M-$1.85M
2025-06-30-$799,890.00-$1.98M-$1.98M
2025-03-31-$15.56M-$15.94M-$15.94M
2024-12-31-$667,722.00-$765,710.00
2024-09-30-$215,256.00-$216,269.00
2024-06-30-$96,923.00
2024-03-31-$230,970.00
2023-12-31-$150,912.00
2023-09-30-$69,258.00
2023-06-30$1.81M
2023-03-31$2.87M
2022-12-31$2.23M
2022-09-30$1.08M
2022-06-30$120,693.00
2022-03-31-$87,826.00
2021-09-30-$15,310.00
2021-06-30-$2,383.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$6,202.00-$116.00-$19.35M-$24.48M-$24.48M
2024-12-31-$1.21M-$1.31M-$1.31M
2023-12-31$4.46M
2022-12-31$3.34M